Table 3

The proportion of reported respiratory symptoms in patients with COVID-19 at baseline by continent

ReferenceRespiratory symptoms
CoughCough productive/
expectoration/sputum
Dyspnoea/
shortness of breath
Chest tightnessChest pain
America (North)1082*ND82†NDND
1590*90†
114876
Range(48–90)(76–90)
Asia9NDNDNDNDND
26683419
38334151
5546ND7
43378
448140
457923ND
47NDND
2763324
2258321113
3675ND3737ND
19592731ND
3448419
49779139*
56DNQDNQNDND
5760ND
17621
3982312
416033NDND
587818116
596312NDND
2559194222
3764ND38ND4
48DNQNDND
608253
50552929209
424524NDND
298156ND
76444122
40387‡7*ND
184NDNDND
3077642
2045258ND
2847ND14§14 *
616419ND
62762855
24502415
466616ND9
1359ND41ND
12DNQND
8572910
6343NDND
35475
2168ND
67718
164615
2392ND
6464279
65DNQNDDNQDNQ
32NDND
3118
3383ND11
Range(4–92)(4–56)(1–64)(5–37)(2–14)
Europe1448ND7NDND
Range(48)(7)
Range(4–92)(4–56)(1–90)(5–37)(2–14)
  • *Or dyspnoea.

  • †Or cough.

  • ‡Or chest tightness.

  • §Or chest pain.

  • DNQ, described but not quantified; ND, not described; Ref, reference.